Medicine
Rhopressa 0.2 mg/mL eye drops
Rhopressa 0.2 mg/mL eye drops is a prescription medicine containing Netarsudil for ophthalmic, topical use, marketed by Alcon Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store at 2°C to 8°C (36°F to 46°F) until opened. During shipment, the bottle…
Key facts
- Active ingredient (INN)
- Netarsudil
- Brand
- Rhopressa
- Strength
- 0.2 mg/mL
- Dosage form
- Eye drops
- Route
- Ophthalmic, topical
- Packs
- 1 bottle
- Marketing authorisation holder
- Alcon Laboratories
- Manufacturer
- Alcon Laboratories
- Origin register
- US FDA, United States
- Storage
- Store at 2°C to 8°C (36°F to 46°F) until opened. During shipment, the bottle may be maintained at temperatures up to 40°C (104°F) for a period not exceeding 14 days. After opening, the product may be kept at 2°C to 25°C (36°F to 77°F) for up to 6 weeks.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- S01EX05 Netarsudil
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 December 2017
- Identifiers
- RxCUI 1992868, 1992873DailyMed set ID 7d4f0e3a-5b86-4c43-982a-813b22ae7e22NDC 70727-497Application NDA208254
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 2.5 mL in 1 bottle | 70727-497-25 | Alcon Laboratories | 18 December 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Netarsudil is a rho kinase inhibitor indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. It is available as eye drops for ophthalmic and topical use. MedsAcross supplies Netarsudil for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NetarsudilFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Rhopressa prescribing information (Alcon Laboratories) · U.S. National Library of Medicine, DailyMed
- Rhokiinsa: European public assessment report (EPAR) · European Medicines Agency
Need Rhopressa 0.2 mg/mL eye drops for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.